论文信息 - Uveal malignant melanoma and levodopa therapy in Parkinson's disease.

Uveal malignant melanoma and levodopa therapy in Parkinson's disease.

Abstract Of three patients who used Levodopa as therapy in Parkinson's disease, two developed a malignant melanoma of the choroid, the third a malignant melanoma of the ciliary body. The possible connection between Parkinson's disease, Levodopa therapy and malignant melanoma, until now only described for cutaneous melanomata, will be discussed.

[1] M. Wick,et al. Levodopa therapy and malignant melanoma. , 1978, JAMA.

[2] A. Barbeau,et al. Long‐term appraisal of levodopa therapy , 1972, Neurology.

[3] M. Wick,et al. Levodopa and Melanoma-Reply , 1979 .

[4] J. Shupack,et al. Levodopa and melanoma , 1974, Neurology.

[5] N. Davis,et al. Multiple primary cutaneous melanomas. , 1975, Archives of dermatology.

[6] M. Wick,et al. Selective toxicity of 6-hydroxydopa for melanoma cells. , 1979, The Journal of investigative dermatology.

[7] E. Gilbert,et al. Multiple primary melanoma following administration of levodopa. , 1972, Archives of pathology.

[8] K. Soltani,et al. Levodopa administration and multiple primary cutaneous melanomas. , 1980, Archives of dermatology.

[9] B. Hirshowitz,et al. Exposure to asbestos and the genesis of pleural plaques and neoplasia. , 1973 .

[10] L. Zimmerman,et al. Melanocytic tumors of interest to the ophthalmologist. , 1980, Ophthalmology.

[11] M. Wick. L-Dopa methyl ester as a new antitumour agent , 1977, Nature.